Skip to main content
Article
Immunogenic compositions comprising silicified virus and methods of use
Technology Transfer - Patents
  • Kenneth M Stedman
  • James R Laidler
  • Keith Bahjat
Document Type
Patent
File Date
7-28-2015
Abstract

It is disclosed herein that viruses coated in silica retain infectivity and the capacity to induce an immune response in an infected host. In addition, silicified virus is remarkably resistant to desiccation. Provided herein are methods of inducing a virus-specific immune response in a subject by administering to the subject an effective amount of silicified virus or silicified virus particles. Methods of enhancing a virus-specific cell-mediated immune response (such as a T cell-mediated immune response) in a subject by administering to the subject a silicified virus or silicified virus particles are also described herein. Further provided are immunogenic compositions comprising silicified virus or silicified virus particles, such as compositions useful as vaccines. The immunogenic compositions include a pharmaceutically acceptable carrier and/or an adjuvant.

Department
Allergy & Immunology
Location
United States
Comments

Patent Number: 9,993,543

Assignee
Portland State University (Portland, OR); Providence Health & Services--Oregon (Portland, OR)
Family ID
51263001
Serial Number
14/763,947
Tech ID
12-02-INV-F
Citation Information
Kenneth M Stedman, James R Laidler and Keith Bahjat. "Immunogenic compositions comprising silicified virus and methods of use" (2015)
Available at: http://works.bepress.com/kenneth_stedman/28/